The University of Chicago Header Logo

Connection

Hedy Kindler to Carbazoles

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Carbazoles.
Hedy Kindler
Connection Strength
0.062
Carbazoles
  1. Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor. Invest New Drugs. 2005 Jan; 23(1):31-7.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.